Next report date
Report period
Q1 2024
EPS estimate
−0.93CHF
Revenue estimate
118.56 MCHF
−2.154CHF
−308.39 MCHF
663.15 MCHF
133.94 M
About Ionis Pharmaceuticals, Inc.
Sector
CEO
Brett P. Monia
Headquarters
Carlsbad
Website
Employees (FY)
927
Founded
1989
FIGI
BBG007FJP026
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ISI is 37.059 CHF — it has decreased by 8.04% in the past 24 hours. Watch IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 stocks are traded under the ticker ISI.
IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ISI stock is 8.75% volatile and has beta coefficient of 1.00. Track IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 stock price on the chart and check out the list of the most volatile stocks — is IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 there?
ISI earnings for the last quarter are −0.94 CHF per share, whereas the estimation was −0.92 CHF resulting in a −2.15% surprise. The estimated earnings for the next quarter are −0.68 CHF per share. See more details about IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 earnings.
IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 revenue for the last quarter amounts to 131.83 M CHF despite the estimated figure of 125.30 M CHF. In the next quarter revenue is expected to reach 146.60 M CHF.
Yes, you can track IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 financials in yearly and quarterly reports right on TradingView.
ISI stock hasn't changed in a week, the month change is a 10.75% fall, over the last year IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 has showed a 5.66% increase.
ISI net income for the last quarter is −7.58 M CHF, while the quarter before that showed −134.95 M CHF of net income which accounts for 94.39% change. Track more IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 financial stats to get the full picture.
Today IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 has the market capitalization of 5.57 B, it has decreased by 3.62% over the last week.
No, ISI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ISI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
As of May 5, 2024, the company has 927.00 employees. See our rating of the largest employees — is IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 on this list?
We've gathered analysts' opinions on IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 future price: according to them, ISI price has a max estimate of 77.57 CHF and a min estimate of 26.46 CHF. Watch ISI chart and read a more detailed IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 stock forecast: see what analysts think of IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 EBITDA is −278.77 M CHF, and current EBITDA margin is −42.05%. See more stats in IONIS PHARMACEUTICALS INC REG. SHARES DL-,001 financial statements.